- Home
- ITCI vs CIGI Comparison
ITCI vs CIGI Comparison
Compare ITCI & CIGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITCI
- CIGI
- Stock Information
- Founded
- ITCI 2002
- CIGI 1972
- Country
- ITCI United States
- CIGI Canada
- Employees
- ITCI N/A
- CIGI N/A
- Industry
- ITCI Biotechnology: Pharmaceutical Preparations
- CIGI
- Sector
- ITCI Health Care
- CIGI
- Exchange
- ITCI Nasdaq
- CIGI Nasdaq
- Market Cap
- ITCI 8.0B
- CIGI 8.0B
- IPO Year
- ITCI N/A
- CIGI N/A
- Fundamental
- Price
- ITCI $86.00
- CIGI $136.74
- Analyst Decision
- ITCI Strong Buy
- CIGI Buy
- Analyst Count
- ITCI 12
- CIGI 6
- Target Price
- ITCI $97.67
- CIGI $163.08
- AVG Volume (30 Days)
- ITCI 455.4K
- CIGI 95.5K
- Earning Date
- ITCI 02-20-2025
- CIGI 02-06-2025
- Dividend Yield
- ITCI N/A
- CIGI 0.22%
- EPS Growth
- ITCI N/A
- CIGI 586.57
- EPS
- ITCI N/A
- CIGI 3.10
- Revenue
- ITCI $613,728,000.00
- CIGI $4,555,575,000.00
- Revenue This Year
- ITCI $48.41
- CIGI $11.69
- Revenue Next Year
- ITCI $38.26
- CIGI $11.88
- P/E Ratio
- ITCI N/A
- CIGI $44.80
- Revenue Growth
- ITCI 46.08
- CIGI 5.40
- 52 Week Low
- ITCI $62.78
- CIGI $101.01
- 52 Week High
- ITCI $93.45
- CIGI $156.96
- Technical
- Relative Strength Index (RSI)
- ITCI 54.91
- CIGI 32.98
- Support Level
- ITCI $82.76
- CIGI $133.84
- Resistance Level
- ITCI $89.12
- CIGI $149.61
- Average True Range (ATR)
- ITCI 2.48
- CIGI 2.87
- MACD
- ITCI -0.04
- CIGI -1.26
- Stochastic Oscillator
- ITCI 59.75
- CIGI 15.16
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.
About CIGI Colliers International Group Inc. Subordinate Voting Shares
Colliers International Group Inc is a real estate services and investment management company. The company provides commercial real estate professional services and investment management to corporate and institutional clients around the world. It's primary service lines are Outsourcing & Advisory, Investment Management, Leasing and Capital Markets. Operationally, company is organized into four distinct segments: Americas; Europe, Middle East and Africa, Asia and Australasia and Investment Management.